Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

被引：0
|
作者：
Majd Issa
Brett G. Klamer
Nikol Mladkova
Georgios I. Laliotis
Vidhya Karivedu
Priyanka Bhateja
Chase Byington
Khaled Dibs
Xueliang Pan
Arnab Chakravarti
John Grecula
Sachin R. Jhawar
Darrion Mitchell
Sujith Baliga
Matthew Old
Ricardo L. Carrau
James W. Rocco
Dukagjin M. Blakaj
Marcelo Bonomi
机构：
[1] The Ohio State University Wexner Medical Center,Department of Internal Medicine, Division of Medical Oncology
[2] The Ohio State University,Center for Biostatistics, Department of Biomedical Informatics
[3] The Ohio State University Wexner Medical Center,Division of Radiation Oncology
[4] Johns Hopkins University,Sidney Kimmel Comprehensive Cancer Center and Department of Oncology
[5] The Ohio State University Wexner Medical Center,Department of Otolaryngology
来源：
BMC Cancer | / 22卷
关键词：
Head and neck cancer; Head and neck squamous cell carcinoma; Immunotherpay; Immune checkpoint inhibitors; Survival in head and neck cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma
    Daoliang Song
    Jie Tian
    Xuefeng Han
    Xin Li
    European Archives of Oto-Rhino-Laryngology, 2021, 278 : 3467 - 3477
  • [32] Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck.
    Even, Caroline
    Martin, Nicolas
    Borcoman, Edith
    Auperin, Anne
    Torossian, Nouritza
    Baste, Neus
    Guigay, Joel
    Le Tourneau, Christophe
    Saada, Esma
    Daste, Amaury
    Saleh, Khalil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Incidence of hypothyroidism in head and neck squamous cell carcinoma patients receiving radiotherapy with and without immune checkpoint inhibitors.
    Leddon, Jennifer
    Chirra, Martina
    Agrawal, Arushi
    Roof, Logan
    Trotier, Danny
    Shaikh, Hira
    Stone, Timothy
    Jandarov, Roman
    Takiar, Vinita
    Wise-Draper, Trisha Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with squamous cell carcinoma of the head and neck.
    Saleh, Khalil
    Daste, Amaury
    Martin, Nicolas
    Pons-Tostivint, Elvire
    Auperin, Anne
    Herrera-Gomez, Ruth Gabriela
    Baste, Neus
    Bidault, Francois
    Guigay, Joel
    Le Tourneau, Christophe
    Saada, Esma
    Even, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Evaluation of the correlation between antibiotic use and survival in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs).
    Vellanki, Paz J.
    Marur, Shanthi
    Bandaru, Pradeep
    Mishra-Kalyani, Pallavi Shruti
    By, Kunthel
    Girvin, Andrew
    Chatterjee, Somak
    Singh, Harpreet
    Keegan, Patricia
    Larkins, Erin A.
    Cross, Frank
    Pazdur, Richard
    Theoret, Marc R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Novel Prognostic Model Based on Immune Signature for Head and Neck Squamous Cell Carcinoma
    Wang, Yingying
    Xu, Yu
    Hua, Qingquan
    Jiang, Yang
    Liu, Peiqiang
    Zhang, Wei
    Xiang, Rong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [37] Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
    dos Santos, Lucas, V
    Abrahao, Carina M.
    William, William N.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] A nomogram based prognostic score to predict overall survival (OS) in recurrent-metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Mousa, L.
    Issa, M.
    Klamer, B.
    Pan, J.
    Old, M.
    Kang, S.
    Agrawal, A.
    Ozer, E.
    Carrau, R.
    Bhateja, P.
    Rupert, R.
    Jhawar, S.
    Mitchell, D.
    Gamez, M.
    Rocco, J.
    Blakaj, D.
    Bonomi, M. R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [39] Prognostic nomograms based on immune scores for head–neck squamous cell carcinoma patients
    Wenfei Li
    Kun Zhao
    Zhanqiu Wang
    European Archives of Oto-Rhino-Laryngology, 2021, 278 : 2493 - 2500
  • [40] Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma
    Zhang, Xue-Mei
    Song, Ling-Jun
    Shen, Juan
    Yue, Hao
    Han, Ya-Qin
    Yang, Chen-Ling
    Liu, Shi-Yun
    Deng, Jia-Wen
    Jiang, Yue
    Fu, Guo-Hui
    Shen, Wei-Wei
    HUMAN PATHOLOGY, 2018, 82 : 104 - 112
12345